Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report

Clin Lung Cancer. 2023 Mar;24(2):e60-e64. doi: 10.1016/j.cllc.2022.11.006. Epub 2022 Nov 26.
No abstract available

Keywords: Immunotherapy; Multimodality therapy; Multisystem; Toxicity; Treatment.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Immunotherapy / adverse effects
  • Lung Neoplasms* / therapy

Substances

  • Immune Checkpoint Inhibitors
  • Antibodies, Monoclonal